FibroGen Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
FGEN Nasdaq 8731 https://www.fibrogen.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for FibroGen Inc

FibroGen (NASDAQ:FGEN investor five-year losses grow to 60% as the stock sheds US$145m this past week - Mar 24th, 2023 2:21 pm
FibroGen, Inc. (NASDAQ:FGEN) Q4 2022 Earnings Call Transcript - Mar 11th, 2023 8:27 am
Q4 2022 FibroGen Inc Earnings Call - Feb 28th, 2023 7:43 pm
FibroGen (FGEN) Reports Q4 Loss, Tops Revenue Estimates - Feb 27th, 2023 10:25 pm
FibroGen Reports Fourth Quarter and Full Year 2022 Financial Results - Feb 27th, 2023 9:01 pm
FibroGen to Present at Cowen’s 43rd Annual Health Care Conference - Feb 27th, 2023 12:00 pm
Should You Buy FibroGen (FGEN) Ahead of Earnings? - Feb 23rd, 2023 4:33 pm
4 Drug, Biotech Stocks Poised to Beat Q4 Earnings Estimates - Feb 23rd, 2023 12:46 pm
Analysts Estimate ImmunoGen (IMGN) to Report a Decline in Earnings: What to Look Out for - Feb 22nd, 2023 3:00 pm
FibroGen (FGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Feb 20th, 2023 3:00 pm
FibroGen to Report Fourth Quarter and Full Year 2022 Financial Results - Feb 17th, 2023 12:00 pm
FibroGen to Present at SVB Securities Global Biopharma Conference - Feb 2nd, 2023 12:00 pm
With 73% ownership in FibroGen, Inc. (NASDAQ:FGEN), institutional investors have a lot riding on the business - Jan 16th, 2023 2:34 pm
FibroGen to Participate at Bank of America 2022 Biotech SMID Cap Virtual Conference - Nov 28th, 2022 12:00 pm
FibroGen Third Quarter 2022 Earnings: Misses Expectations - Nov 9th, 2022 10:15 am
FibroGen (FGEN) Reports Q3 Loss, Misses Revenue Estimates - Nov 7th, 2022 10:45 pm
FibroGen Reports Third Quarter 2022 Financial Results - Nov 7th, 2022 9:01 pm
FibroGen Announces $50 Million Royalty Monetization Financing with NovaQuest Capital Management - Nov 7th, 2022 9:00 pm
FibroGen to Participate at Stifel 2022 Healthcare Conference - Nov 1st, 2022 11:00 am
Earnings Preview: FibroGen (FGEN) Q3 Earnings Expected to Decline - Oct 31st, 2022 2:00 pm